Pike Therapeutics Inc. — Form D
Pike Therapeutics Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-24. The offering totals $175K, of which $175K was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-09-24
- Form: D
- Accession: 0001884336-21-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $175K
- Amount sold: $175K
- Investors: 4
- Date of first sale: 2021-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-414453
Issuer
- Name: Pike Therapeutics Inc.
- CIK: 0001884336
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2019
- Address: 20TH FLOOR, 250 HOWE STREET, VANCOUVER, A1, V6C 3R8
- Phone: 416-509-6509
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| MARK PURDY | Director | VANCOUVER, A1 |
| MARK PURDY | Related Person | VANCOUVER, A1 |
| IAN FODIE | Director | VANCOUVER, A1 |
| IAN FODIE | Executive Officer | VANCOUVER, A1 |
| IAN FODIE | Related Person | VANCOUVER, A1 |
| BRADLEY MILES | Director | VANCOUVER, A1 |
| BRADLEY MILES | Executive Officer | VANCOUVER, A1 |
| BRADLEY MILES | Related Person | VANCOUVER, A1 |
Other filings by this issuer (2)
More